Article
Interferon-beta inhibits Th1 responses at the dendritic cell level. Relevance to multiple sclerosis.
Acta neurologica Belgica - 1 Mar 1999
Bartholomé E J, Willems F, Crusiaux A, Thielemans K, Schandené L, Goldman M
Abstract excerpt
Clinical studies have demonstrated beneficial effects of interferon-beta (IFN-beta) therapy in multiple sclerosis (MS) patients. However, the mechanism of action of IFN-beta in MS remains unknown. IFN-beta has even been demonstrated to enhance isolated T cell secretion of IFN-gamma, a cytokine pr...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
